https://www.marketscreener.com/news/latest/Astex-Pharmaceuticals-Presents-Overall-Survival-Data-From-ASCERTAIN-Phase-3-Study-of-Oral-Hypomethyl-36505329/?utm_source=telegram&utm_medium=social&utm_campaign=share